Faro Health develops software to assists clinical development processes, including workflow automation and clinical trial design.
Faro AI has raised $37.3M in total funding. The most recent round was Series B. The last funding was announced in August 2026.
Faro AI's investors include General Catalyst, S32, Zetta Venture Partners, Polaris Partners, Ankona Capital.
Faro AI is headquartered in La Jolla, United States.
Faro Health develops software to assists clinical development processes, including workflow automation and clinical trial design.
Faro AI is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Faro AI — Funding & Investors." VCBacked, August 26, 2026, https://www.vcbacked.co/company/faro-ai. Accessed October 17, 2026.
VCBacked. (2026). Faro AI — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/faro-ai
{{cite web |title=Faro AI — Funding & Investors |url=https://www.vcbacked.co/company/faro-ai |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated